Company Filing History:
Years Active: 2024-2025
Title: Fouad Moussa: Innovator in Cancer Treatment
Introduction
Fouad Moussa is a notable inventor based in Allentown, PA, who has made significant contributions to the field of cancer treatment. With a total of three patents to his name, he has focused on developing innovative therapies that target specific cancer markers.
Latest Patents
Moussa's latest patents include the development of novel anti-CD28 x anti-PSMA antibodies. These antibodies are designed to treat PSMA-associated cancers by agonistically binding to CD28 costimulatory molecules on T cells and PSMA on tumor cells. This unique mechanism allows for enhanced anti-tumor activity at tumor sites while minimizing peripheral toxicity. The antibodies are particularly useful when combined with other anti-cancer therapies, such as anti-CD3 x anti-PSMA antibodies, for the treatment of prostate cancers.
Career Highlights
Throughout his career, Fouad Moussa has worked with prominent companies in the biotechnology sector, including Xencor, Inc. and Abzyme Therapeutics LLC. His work has been instrumental in advancing therapeutic options for cancer patients.
Collaborations
Moussa has collaborated with esteemed colleagues, including John R. Desjarlais and Gregory L. Moore, contributing to the development of innovative cancer therapies.
Conclusion
Fouad Moussa's work in developing anti-CD28 x anti-PSMA antibodies represents a significant advancement in cancer treatment. His innovative approach and collaborations highlight his commitment to improving patient outcomes in the fight against cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.